Signed in as:
filler@godaddy.com
Signed in as:
filler@godaddy.com

The Legon Pharmaceutical and Innovation Park (LePIP) is a flagship initiative of the Government of Ghana, a Special Economic Zone designed to make Ghana a leading biopharmaceutical and pharmaceutical manufacturing hub in West Africa.
LePIP integrates research, development, manufacturing, and commercialization within a single innovation cluster. The park is engineered to host a dense ecosystem of biotech companies systematically transforming raw academic research into market-ready commercial products.
Its strategic objective: take pharmaceutical production on the continent from less than 1% to 60% in line with the Africa CDC PAVM target and the WHO Afro continental manufacturing agenda.
An industrial park strength lies in its innovation nursery. Zeme is the layer that creates startups from ideas, prototypes and patents. We provide the biomanufacturing lines, the lab services, the AI platform, the hub-operations team, and seed capital. When a tenant graduates the studio, it moves into build-to-suit GMP suites at LePIP.
To learn more about our groundbreaking work and services, visit service page

A governing body composed of lead investors, Development Finance Institutions, and senior technical experts responsible for oversight, accountability, and long-term strategic stewardship of Zeme.

A distinguished group of senior scientific and industry leaders who provide high-level guidance, insight, and strategic direction to Zeme, without direct operational or management responsibilities.

The executive leadership team responsible for day-to-day management of Zeme, driving execution across the hub, platform, and resident company portfolio.

Zeme is led by a multidisciplinary team of scientists, biotech entrepreneurs, and ecosystem builders with expertise spanning genomics, diagnostics, drug discovery, agricultural biotechnology, and research infrastructure across Africa and globally. The team brings a strong track record in establishing laboratories, developing scientific talent, incubating biotech ventures, and translating research into commercial and public health solutions. Supported by active partnerships with leading hubs in Boston and San Francisco, as well as key European ecosystems, Zeme leverages global networks to drive technology transfer, investment, and diaspora-led collaboration.

Ghana stands at the center of a growing global innovation network, where Zeme Life Sciences is transforming ideas, prototypes, and patents into scalable biotech startups aligned with the nation’s 24-hour economy agenda. Anchored within the Legon Pharmaceutical and Innovation Park, Zeme is helping drive Ghana’s ambition to expand pharmaceutical and biotech production from less than 1% to over 60%, while attracting global innovators, investors, and partners. By connecting local talent with leading ecosystems in Boston, San Francisco, Europe, and Asia, Zeme positions Ghana as the biotech gateway to West Africa—enabling research commercialization, technology transfer, and the development of globally competitive products.

Zeme builds and scales science-driven ventures that transform African research and innovation into commercially viable, high-impact solutions for health, agriculture, and the bioeconomy.

Zeme deploys patient, impact-oriented capital paired with active management to accelerate the growth of scalable biotechnology and life sciences ventures in Ghana and across Africa.
To position Ghana as the leading biotechnology gateway in West Africa
To transform research and intellectual property into scalable biotech ventures by providing the infrastructure, expertise, and support needed to accelerate product development for Africa and global markets.
Zeme advances innovation through strong Pan-African collaboration and global partnerships that connect researchers, startups, institutions, and investors across borders. By leveraging regional networks and international expertise, we accelerate knowledge transfer, co-development, and market access, enabling African innovations to scale regionally and compete globally.
Investing in Zeme offers the opportunity to support scalable, high-impact biotechnology and life sciences ventures that address critical health, agricultural, and bioeconomic challenges in Africa. With a unique combination of patient capital, hands-on management, shared research infrastructure, and strong local and global partnerships, Zeme de-risks early-stage innovation, accelerates commercialization, and delivers measurable social, economic, and financial returns. Investors gain exposure to a growing market with significant unmet needs, while contributing to sustainable development and scientific advancement on the continent.
Zeme drives socioeconomic transformation by catalyzing science-based enterprises that create skilled jobs, strengthen local industries, and improve access to essential health and agricultural solutions. Through inclusive innovation and sustainable investment, we contribute to economic growth, resilience, and improved quality of life in Ghana and across African communities.
Africa is at a pivotal moment where rising health and food security needs, a growing scientific talent base, and supportive policy and investment trends are converging. Advances in biotechnology, digital tools, and manufacturing, combined with increased global interest in resilient supply chains and impact investing, create a timely opportunity to scale Africa-led bioinnovation. Zeme is positioned to act now, bridging capital, infrastructure, and expertise to unlock this momentum and deliver lasting impact and returns.




Copyright © 2026 Zeme Consult LLC - All Rights Reserved.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.